Mayo Clinic Oncologist
To Receive ACCC Clinical Research Award
ROCHESTER, Minn. -- Charles Loprinzi, M.D., a Mayo Clinic oncologist, will receive the Association of Community Cancer Centers (ACCC) Annual Clinical Research Award on Friday in his hometown of Portland, Ore., in recognition of his significant clinical research activities. Dr. Loprinzi is past chair of the Division of Medical Oncology at Mayo Clinic in Rochester and a key investigator in the North Central Cancer Treatment Group.
"I am honored to receive this award, and even more honored to be able to work every day with talented colleagues, at Mayo and in the North Central Cancer Treatment Group, all striving for the same goal -- to alleviate suffering and prolong life for cancer patients," says Dr. Loprinzi.
Dr. Loprinzi's research efforts include studies of ways to prevent cancer and the pain and illness that accompany cancer treatment. He has also looked at ways to screen individuals for early detection of cancer and has studied numerous complementary and alternative therapies for potential use by cancer patients.
Highlights from Dr. Loprinzi's career include his research to find ways to reduce cancer-induced anorexia, resulting in the definition of several medications' effectiveness, or lack thereof. He continues, with his colleagues, to study additional means to enhance appetites in patients with cancer. Dr. Loprinzi also has led research efforts that have made significant inroads into finding effective treatments for cancer treatment-induced hot flashes in men and in postmenopausal women.
An internationally recognized cancer expert, Dr. Loprinzi has published more than 250 articles and book chapters. He also serves as the founding editor for the Art of Oncology section of the Journal of Clinical Oncology.
The award will be presented at ACCC's 22nd National Oncology Economics Conference.